CIK 0001108205 · Non-accelerated filer<br>Smaller reporting company
CURIS INC
Sign in to watch- Ticker
- CRIS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043505116
- Phone
- 617-503-6500
- Business address
- 128 SPRING STREET, BUILDING C, SUITE 500, LEXINGTON, MA, 02421
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-29 | Steinkrauss William Chief Financial Officer | Grant or award · Employee stock option (right to buy) | +360,000 | 360,000 | ||
| 2022-01-29 | Martell Robert Head of Research & Development | Grant or award · Employee stock option (right to buy) | +252,000 | 252,000 | ||
| 2022-01-29 | Dentzer James E President & CEO | Grant or award · Employee stock option (right to buy) | +825,000 | 825,000 | ||
| 2022-01-27 | Dentzer James E President & CEO | Sale | −2,406 | $3.18 | $8K | 67,971 |
| 2021-12-02 | Hohneker John Director | Grant or award · Non Qualified Stock Option | +25,000 | 25,000 | ||
| 2021-01-28 | GREENACRE MARTYN D Director | Grant or award · Non Qualified Stock Option | +33,000 | 33,000 | ||
| 2021-01-28 | Martell Robert Head of Research & Development | Grant or award · Employee stock option (right to buy) | +126,000 | 126,000 | ||
| 2021-01-28 | Rubin Marc Director | Grant or award · Non Qualified Stock Option | +33,000 | 33,000 | ||
| 2021-01-28 | Steinkrauss William Chief Financial Officer | Grant or award · Employee stock option (right to buy) | +180,000 | 180,000 | ||
| 2021-01-28 | Dentzer James E President & CEO | Grant or award · Employee stock option (right to buy) | +330,000 | 330,000 | ||
| 2021-01-28 | Kunkel Lori Anne Director | Grant or award · Non Qualified Stock Option | +33,000 | 33,000 | ||
| 2021-01-28 | KAITIN KENNETH I Director | Grant or award · Non Qualified Stock Option | +33,000 | 33,000 | ||
| 2021-01-26 | Dentzer James E President & CEO | Sale | −3,094 | $10.59 | $33K | 67,268 |
| 2021-01-25 | Dentzer James E President & CEO | Sale | −2,283 | $10.96 | $25K | 70,362 |
| 2020-03-02 | KAITIN KENNETH I Director | Grant or award · Non Qualified Stock Option | +180,000 | 180,000 | ||
| 2020-03-02 | Kunkel Lori Anne Director | Grant or award · Non Qualified Stock Option | +180,000 | 180,000 | ||
| 2020-03-02 | Rubin Marc Director | Grant or award · Non Qualified Stock Option | +180,000 | 180,000 | ||
| 2020-03-02 | GREENACRE MARTYN D Director | Grant or award · Non Qualified Stock Option | +180,000 | 180,000 | ||
| 2020-03-02 | Steinkrauss William Chief Financial Officer | Grant or award · Employee stock option (right to buy) | +385,000 | 385,000 | ||
| 2020-03-02 | Martell Robert Head of Research & Development | Grant or award · Employee stock option (right to buy) | +385,000 | 385,000 |
Page 5 of 17 · 326 trades